Nitisinone
Product Specifications
Background
Inhibitor of 4-Hydroxyphenylpyruvate dioxygenase (HPPD; IC50 = 40 nM1 and 173 nM2) and is in clinical use for the treatment of hereditary tyrosinemia type 13. CD13+ cancer stem cells (CSCs) are dependent on aerobic metabolism of tyrosine - Nitisinone inhibition of tyrosine metabolism results in lowered availability of acetyl-CoA and fumarate for use in the citric acid cycle causing these CSCs to enter cell cycle, decreasing self-renewal, and making them more susceptible to chemotherapy.4 Nitisinone is a potential treatment option for cancers that rely on tyrosine metabolism.
Conjugation
Unconjugated
Buffer
Beige solid
Storage Conditions
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6133429-01 0.1 mL
RIN2 (Ras and Rab Interactor 2, MACS, Ras Association Domain Family 4, RASSF4, Ras Inhibitor JC265, Ras Interaction/interference Protein 2) (AP)
Sign In for Pricing
View Details MBS6133429-02 5x 0.1 mL
RIN2 (Ras and Rab Interactor 2, MACS, Ras Association Domain Family 4, RASSF4, Ras Inhibitor JC265, Ras Interaction/interference Protein 2) (AP)
Sign In for Pricing
View Details 
LV649879 1.0 µg DNA
FAM3B Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details NBP1-76872MFV610 0.1 mL
Rabbit Polyclonal CX3CR1 Antibody [mFluor Violet 610 SE]
Sign In for Pricing
View Details